Søgeresultater - Bikash Verma
- Showing 1 - 2 results of 2
-
1
NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient af David A. Sallman, Jason Brayer, Elizabeth M. Sagatys, Caroline Lonez, Eytan Breman, Sophie Agaugué, Bikash Verma, David E. Gilham, Frédéric Lehmann, Marco L. Davila
Udgivet 2018Artigo -
2
Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metast... af Caroline Lonez, Bikash Verma, Alain Hendlisz, Philippe Aftimos, Ahmad Awada, Eric Van Den Neste, Gaëtan Catala, Jean‐Pascal Machiels, Fanny Piette, Jason Brayer, David A. Sallman, Tessa Kerre, Kunle Odunsi, Marco L. Davila, David E. Gilham, Frédéric Lehmann
Udgivet 2017Artigo
Søgeredskaber:
Relaterede emner
Medicine
Alternative medicine
Astrobiology
Biochemistry
Biology
Cancer research
Chemotherapy
Chimeric antigen receptor
Complete remission
Cytotoxicity
Immune system
Immunology
Immunotherapy
In vitro
Internal medicine
Law
Multinational corporation
Myeloid leukemia
NKG2D
Oncology
Pathology
Political science
Protocol (science)
Receptor
Refractory (planetary science)